Vyome Holdings, Inc (HIND) stock
HINDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.58−0.05 (-3.07%)
Close on Nov 13, 2026Market cap $11.09MP/E –Yield –
Vyome operating margin
Operating margin is operating income as a percentage of revenue.
Vyome's operating margin for the twelve months ending Sep 30, 2026 was -2853.6%. For fiscal 2025 it was -3269.4%, against -391.7% the year before. The highest annual figure on record is -110.2% in fiscal 2020.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -3269.4% | −2877.7 |
| FY2024 | Dec 31, 2024 | -391.7% | −214.4 |
| FY2023 | Dec 31, 2023 | -177.3% | +235.1 |
| FY2022 | Dec 31, 2022 | -412.4% | +13.2 |
| FY2021 | Dec 31, 2021 | -425.6% | −315.4 |
| FY2020 | Dec 31, 2020 | -110.2% | +597.8 |
| FY2019 | Dec 31, 2019 | -708.0% | −301.9 |
| FY2018 | Dec 31, 2018 | -406.2% | −59.3 |
| FY2017 | Dec 31, 2017 | -346.9% | +228.0 |
| FY2016 | Dec 31, 2016 | -574.9% | −205.1 |
| FY2015 | Dec 31, 2015 | -369.7% | −91.7 |
| FY2014 | Dec 31, 2014 | -278.0% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -1760.6% | +23001.3 |
| Q2 FY2026 | Jun 30, 2026 | -3200.0% | −2551.0 |
| Q1 FY2026 | Mar 31, 2026 | -3576.8% | −3476.6 |
| Q4 FY2025 | Dec 31, 2025 | -3707.4% | −3290.6 |
| Q3 FY2025 | Sep 30, 2025 | -24761.9% | −24429.5 |
| Q2 FY2025 | Jun 30, 2025 | -649.0% | −544.4 |
| Q1 FY2025 | Mar 31, 2025 | -100.2% | +13.5 |
| Q4 FY2024 | Dec 31, 2024 | -416.8% | −321.1 |
| Q3 FY2024 | Sep 30, 2024 | -332.4% | −152.4 |
| Q2 FY2024 | Jun 30, 2024 | -104.5% | +71.9 |
| Q1 FY2024 | Mar 31, 2024 | -113.7% | +132.5 |
| Q4 FY2023 | Dec 31, 2023 | -95.6% | +441.1 |
| Q3 FY2023 | Sep 30, 2023 | -180.0% | +259.6 |
| Q2 FY2023 | Jun 30, 2023 | -176.4% | +143.2 |
| Q1 FY2023 | Mar 31, 2023 | -246.2% | +86.3 |
| Q4 FY2022 | Dec 31, 2022 | -536.8% | +657.3 |
| Q3 FY2022 | Sep 30, 2022 | -439.6% | −50.8 |
| Q2 FY2022 | Jun 30, 2022 | -319.6% | −215.1 |
| Q1 FY2022 | Mar 31, 2022 | -332.5% | −262.4 |
| Q4 FY2021 | Dec 31, 2021 | -1194.0% | −1094.1 |
| Q3 FY2021 | Sep 30, 2021 | -388.9% | −328.6 |
| Q2 FY2021 | Jun 30, 2021 | -104.5% | +71.6 |
| Q1 FY2021 | Mar 31, 2021 | -70.1% | +559.5 |
| Q4 FY2020 | Dec 31, 2020 | -99.9% | +532.2 |
| Q3 FY2020 | Sep 30, 2020 | -60.3% | +1063.4 |
| Q2 FY2020 | Jun 30, 2020 | -176.1% | +1485.3 |
| Q1 FY2020 | Mar 31, 2020 | -629.6% | −173.3 |
| Q4 FY2019 | Dec 31, 2019 | -632.1% | −206.8 |
| Q3 FY2019 | Sep 30, 2019 | -1123.7% | −901.6 |
| Q2 FY2019 | Jun 30, 2019 | -1661.4% | −1309.9 |
| Q1 FY2019 | Mar 31, 2019 | -456.3% | +440.2 |
| Q4 FY2018 | Dec 31, 2018 | -425.3% | −156.6 |
| Q3 FY2018 | Sep 30, 2018 | -222.1% | +105.8 |
| Q2 FY2018 | Jun 30, 2018 | -351.5% | +37.7 |
| Q1 FY2018 | Mar 31, 2018 | -896.6% | −374.1 |
| Q4 FY2017 | Dec 31, 2017 | -268.7% | +707.2 |
| Q3 FY2017 | Sep 30, 2017 | -327.9% | – |
| Q2 FY2017 | Jun 30, 2017 | -389.2% | – |
| Q1 FY2017 | Mar 31, 2017 | -522.5% | – |
| Q4 FY2016 | Dec 31, 2016 | -975.9% | – |
See a number that looks wrong?